Insider · CIK 0001403322
Thomas Malley
Files at KURA (Kura Oncology, Inc.), KNSA (Kiniksa Pharmaceuticals International, plc). First filing Aug 14, 2025, latest Aug 14, 2025.
Thomas Malley files SEC Form 4 as director at KNSA (Kiniksa Pharmaceuticals International, plc), and also at KURA (Kura Oncology, Inc.). Since Aug 14, 2025, Thomas Malley has reported 0 open-market buys worth $0 and 1 open-market sell worth $5.9M, the latest filed on Aug 14, 2025.
A track record needs three past buys with six months of prices behind them; Thomas Malley has 0, so none is measured yet.
The newest scored trade: sold $5.9M of KNSA on Aug 12, 2025, filed Aug 14, 2025, scored 60 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KNSA: Kiniksa Pharmaceuticals International, plc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Kiniksa Pharmaceuticals International, plc | $5.9M 177,769 shares | -287% | +80% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | 78,233 0.18% of outstanding | $2.6M | Aug 14, 2025 | $3.3M |
| Aug 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | 50,129 0.12% of outstanding | $1.7M | Aug 13, 2025 | $1.6M |
| Aug 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | 49,407 0.11% of outstanding | $1.6M | Aug 12, 2025 | none |
Transactions
Every row this insider has filed, 29 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +35,000 | $0.00 | $0 | 35,000 | Jun 4, 2026 |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +2,799 | - | - | 15,345 | Jun 2, 2026 |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +12,158 | $0.00 | $0 | 12,158 | Jun 2, 2026 |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitsderivative | +2,026 | $0.00 | $0 | 2,026 | Jun 2, 2026 |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitsderivative | -2,799 | $0.00 | $0 | 0 | Jun 2, 2026 |
| Mar 18, 2026 | KURA Kura Oncology, Inc. | MOption exercise Common Stock | +10,000 | $3.12 | $31k | 10,000 | Mar 20, 2026 |
| Mar 18, 2026 | KURA Kura Oncology, Inc. | MOption exercise Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 0 | Mar 20, 2026 |
| Aug 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +21,959 | $1.86 | $41k | 34,505 | Aug 14, 2025 |
| Aug 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +27,448 | $3.80 | $104k | 61,953 | Aug 14, 2025 |
| Aug 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Shares | -49,407 | $32.40 | $1.6M | 12,546 | Aug 14, 2025 |
| Aug 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +20,129 | $10.36 | $209k | 32,675 | Aug 14, 2025 |
| Aug 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +30,000 | $9.88 | $296k | 62,675 | Aug 14, 2025 |
| Aug 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Shares | -50,129 | $33.32 | $1.7M | 12,546 | Aug 14, 2025 |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +18,760 | $15.47 | $290k | 31,306 | Aug 14, 2025 |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +33,237 | $14.33 | $476k | 64,543 | Aug 14, 2025 |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +26,236 | $15.19 | $399k | 90,779 | Aug 14, 2025 |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Shares | -78,233 | $33.09 | $2.6M | 12,546 | Aug 14, 2025 |
| Aug 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -21,959 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Aug 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -27,448 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Aug 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -20,129 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Aug 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -30,000 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -18,760 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -33,237 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Aug 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -26,236 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Jun 5, 2025 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +28,500 | $0.00 | $0 | 28,500 | Jun 6, 2025 |
| Jun 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Shares | +3,173 | - | - | 12,546 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +16,798 | $0.00 | $0 | 16,798 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitsderivative | +2,799 | $0.00 | $0 | 2,799 | Jun 5, 2025 |
| Jun 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitsderivative | -3,173 | $0.00 | $0 | 0 | Jun 5, 2025 |
Questions about Thomas Malley
Answered from the filings on this page, as of the latest one.
Is Thomas Malley buying or selling?
Not in the last 12 months. Thomas Malley's latest open-market trade on SEC Form 4 was sold $5.9M of KNSA on Aug 12, 2025.
How did Thomas Malley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Malley has 0.
Where does Thomas Malley file Form 4?
Thomas Malley has filed Form 4 at KNSA (Kiniksa Pharmaceuticals International, plc); KURA (Kura Oncology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.